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OBJECTIVES To compare transesophageal atrial pacing stress echocardiography with dobutamine stress
echocardiography for feasibility, safety, duration, patient acceptance and concordance in
inducing wall motion abnormalities.
BACKGROUND Transesophageal atrial pacing is an effective method of increasing heart rate and has been used
in the assessment of coronary artery disease.
METHODS Both tests were performed in sequence on the same patients in random order. Transesoph-
ageal atrial pacing stress echocardiography began at a heart rate of 10 beats/min above the
baseline value and was increased by 20 beats/min every two min until 85% of the
age-predicted maximum heart rate or another end point was reached. Dobutamine echocar-
diography was performed using three-min stages and a maximum dose of 40 mg/kg per min.
Atropine (total dose #2 mg) was administered at the start of the 40 mg/kg per min stage if
needed to augment heart rate or during pacing if Wenckebach heart block occurred.
RESULTS Transesophageal atrial pacing stress echocardiography was feasible in 100 of 104 patients
(96%); the duration (8.6 6 3.6 min) was significantly shorter than that of dobutamine stress
echocardiography (15.1 6 3.9 min) (p 5 0.0001). With transesophageal atrial pacing stress
echocardiography, the recovery period was shorter, symptoms and dysrhythmias were fewer,
hypertension and hypotension were less common and target heart rate was more frequently
achieved. No complications occurred with either test. Patient acceptance was satisfactory.
Agreement between results of both tests was good for segmental wall motion scoring with a
16-segment model, scores 1 to 5 (kappa: rest, 0.79; peak, 0.57) and test interpretation
(normal, ischemia, infarction or resting wall motion abnormality with ischemia) (kappa:
0.77).
CONCLUSIONS Transesophageal atrial pacing stress echocardiography is a feasible, well-tolerated alternative
to dobutamine stress echocardiography. It can be performed rapidly and shows good
agreement with dobutamine stress echocardiography in the induction of myocardial ischemia.
(J Am Coll Cardiol 1999;33:506–11) © 1999 by the American College of Cardiology
Dobutamine stress echocardiography is a safe and accurate
technique for the detection of significant coronary artery
disease (1–5). The hemodynamic response to dobutamine is
variable; the test may be terminated in some patients
because of hypertension or hypotension (4,5). Adverse
effects may include nausea, headaches, tremors, dysrhyth-
mias and symptoms attributable to intracavitary or left
ventricular outflow tract obstruction that may occur when
the left ventricle is hyperdynamic (6). Additionally, dobut-
amine stress echocardiography is labor intensive, requiring
supervision by trained personnel throughout the period of
drug infusion and recovery. Test duration usually exceeds
that of exercise stress testing.
Transesophageal atrial pacing has been proposed as an
efficient alternative method to increase heart rate and induce
myocardial ischemia (7–14). Early experience with trans-
esophageal pacing has been limited by patient intolerance.
With newer pacing technology, however, experience has
improved (14).
A head-to-head comparison study of dobutamine stress
echocardiography and transesophageal atrial pacing stress
echocardiography has not been done in a large group of
patients. The purpose of the present study was to prospec-
tively compare the safety, feasibility, patient tolerance and
time requirements of both types of stress transthoracic
echocardiography and to determine the concordance of the
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two methods for induction of regional wall motion abnor-
malities.
METHODS
Study patients. The study was approved by the Institu-
tional Review Board of the Mayo Clinic. Outpatients
scheduled for clinically indicated dobutamine stress echo-
cardiography were eligible for the study. Exclusion criteria
were recent myocardial infarction (within two weeks), un-
stable angina, complex ventricular dysrhythmias, uncon-
trolled systemic hypertension, untreated glaucoma, atrial
fibrillation or flutter, permanent pacemaker or defibrillator,
significant valvular disease, complete atrioventricular block,
untreated esophageal stricture, gastroesophageal varices and
recent upper gastrointestinal bleeding. One hundred four
patients gave informed consent for participation in the
study. Antianginal medications were not changed. After
fasting for at least 3 h, each patient underwent transesoph-
ageal atrial pacing stress echocardiography and dobutamine
stress echocardiography in a sequence determined ran-
domly. The second test was started after a 20-min rest
period, which began after a recovery period that ended with
the resolution of any stress-induced evidence of myocardial
ischemia and after heart rate had returned to within 10 beats
of the baseline heart rate.
During both protocols, symptoms, heart rate, blood
pressure, arrhythmias and adverse effects were recorded. At
any stage, one or two mg of midazolam was given intrave-
nously if necessary to alleviate patient anxiety, discomfort or
gagging. The duration of each protocol from start of
dobutamine infusion or start of placement of the transesoph-
ageal atrial pacing catheter to completion of the acquisition
of peak stress images was recorded. The duration of the
recovery period was also recorded. After both tests had been
performed, patients completed a questionnaire, scoring the
tests for comfort and acceptance on a scale of 1 (intolerable)
to 5 (very satisfactory).
Instrumentation. Transthoracic two-dimensional echo-
cardiography was performed with either a Hewlett-Packard
Sonos 2500 (Andover, Massachusetts) or an Acuson XP
128 (Mountain View, California). The complete studies
were recorded on 3/4-in. videotape. Images of baseline and
stress cardiac cycles were digitally stored on a Nova Mi-
croSonics system (Allendale, New Jersey). During trans-
esophageal atrial pacing stress echocardiography, the start-
delay time interval to digital image acquisition was increased
in accordance with the duration between the pacing spike
and R wave because the high-amplitude pacing spike
triggered digital image acquisition. Atrial pacing was per-
formed with a bipolar esophageal cardiac pacing and record-
ing catheter (Pacescope; Cardiocommand, Inc., Tampa,
Florida) housed in a flexible 18-French USC class IV
polyvinyl chloride sheath. The catheter was connected to a
Model 7A stimulator and Model 3 preamplifier (Tapstress
System; Cardiocommand, Inc.) and Hewlett-Packard elec-
trocardiograph for display of atrial signals from the esoph-
ageal electrode.
Protocol for transesophageal atrial pacing stress echocar-
diography. The oropharynx was anesthetized with 10%
lidocaine aerosol, and the pacing catheter was introduced
orally by instructing the patient to swallow. Catheter posi-
tion was optimized by maximizing the size of the esophageal
P wave on the electrocardiogram. Pacing was initiated at 10
beats/min above the patient’s baseline heart rate and at 3 to
5 mA above the threshold for stable atrial capture. A pulse
width of 10 ms was used. The pacing protocol consisted of
2-min stages with the paced heart rates increasing by 20
beats/min at every stage until the target heart rate (85% of
age-predicted maximum) or another end point was reached.
Blood pressure was measured at each stage. If Wenckebach
second-degree heart block occurred, atropine was adminis-
tered intravenously in 0.5-mg increments, to a maximum
dose of 2 mg. End points were target heart rate, new or
worsening wall motion abnormalities of at least moderate
severity, ventricular or supraventricular tachycardia, electro-
cardiographic evidence of severe ischemia (2-mm horizontal
or downsloping ST depression at 80 ms after J point), severe
angina, intolerable symptoms, systolic blood pressure
$240 mm Hg, diastolic blood pressure $120 mm Hg and
systolic blood pressure ,90 mm Hg.
Protocol for dobutamine stress echocardiography. Do-
butamine was infused incrementally by a standard protocol
with 3-min stages (5) and a maximum dose of 40 mg/kg per
min. Atropine was administered intravenously to augment
the heart rate if the target rate or another end point had not
been achieved, starting with 0.25 mg and increasing the
amount to a maximum total dose of 2 mg. In addition, if at
the end of the 30 mg/kg per minute stage the heart rate was
,75% of the age-predicted maximum, atropine was admin-
istered concurrently with an increase of dobutamine to
40 mg/kg per minute. End points were the administration of
maximum doses of dobutamine and atropine in addition to
the end points used for the pacing protocol.
Image analysis and interpretation. Dobutamine and pac-
ing stress echocardiography tests were interpreted by expe-
rienced echocardiologists who were unaware of the results of
the other test. Regional wall motion was evaluated at rest
and at peak stress in each of 16 left ventricular segments by
use of the 1 through 5 scoring system of the American
Society of Echocardiography (15), and the regional wall
motion score index was calculated. A normal response to
stress was characterized by normal or hyperdynamic systolic
function of all left ventricular segments. Infarction was
characterized by resting wall motion abnormalities that did
not change with stress. An akinetic segment that did not
improve but became dyskinetic was considered to represent
infarction (16). The development of new wall motion
abnormalities was considered indicative of myocardial isch-
emia. Worsening of resting wall motion abnormalities,
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including deterioration after initial improvement, was clas-
sified as resting wall motion abnormality with ischemia. The
heart rate at which a new or worsening wall motion
abnormality was first noticed (ischemic threshold) was
recorded. On the basis of wall motion changes induced,
myocardial segments were grouped by coronary artery dis-
tribution (17) and classified as normal, ischemic, infarcted
or resting wall motion abnormality with ischemia. Ejection
fractions at baseline and peak stress were determined by
visual estimation.
Coronary angiography. Fourteen patients underwent clin-
ically indicated coronary angiography within 6 months of
the stress echocardiography protocols. Coronary vessels
were visually assessed, and $50% narrowing of the lumen
diameter of one or more major epicardial vessels was
considered significant.
Statistical analysis and estimation of agreement of re-
sults. Paired Student t test and McNemar’s test were used
for paired continuous data and paired proportions, respec-
tively. A p value of ,0.05 was considered significant. The
degree of agreement between results of dobutamine stress
echocardiography and transesophageal atrial pacing stress
echocardiography was estimated by the kappa coefficient:
kappa of 1 denoted perfect agreement; kappa .0.5, good
agreement; and kappa .0.8, excellent agreement (18). The
agreement between the two tests for producing resting wall
motion abnormalities was evaluated in two ways: 1) com-
parison of wall motion scores 1 through 5 for individual
myocardial segments; and 2) comparison of classification of
each coronary artery territory as normal, ischemic, infarcted
or having resting wall motion abnormalities with ischemia.
RESULTS
Patient characteristics. Dobutamine stress echocardiogra-
phy was performed in all 104 recruited patients. Transesoph-
ageal atrial pacing stress echocardiography was not feasible
in four patients (4%) (three had inconsistent atrial capture;
one patient did not tolerate esophageal intubation). One
hundred patients were successfully paced and formed the
study group. There were 53 men and 47 women; the mean
age was 69 6 10 years (range, 39 to 86 years). The causes of
inability to exercise were orthopedic limitation in 40 pa-
tients, peripheral vascular disease in 29 and other physical
limitations in 31. Indications for stress testing were evalu-
ation of chest pain or dyspnea in 64 patients and evaluation
of known coronary artery disease in 36 patients. Seventeen
patients had a previous myocardial infarction. Twenty had a
history of coronary revascularization, including percutane-
ous angioplasty in 12, bypass grafting in eight, and both in
one. Hypertension, hyperlipidemia and diabetes mellitus
were present in 63, 56 and 17 patients, respectively; 57 were
smokers. Three or more coronary risk factors for atheroscle-
rosis were present in 31 patients. Thirty patients were taking
beta-blocker medications.
Hemodynamic end points and symptoms during stress
echocardiography. During dobutamine stress echocardi-
ography, the mean dobutamine dose was 35 6 9 mg/kg per
min (range, 20 to 40 mg/kg per min). Atropine (mean dose,
0.99 6 0.62 mg; range, 0.25 to 2.0 mg) was administered to
44 patients.
In the transesophageal atrial pacing stress echocardiogra-
phy protocol, the mean pacing threshold was 15.2 6
4.8 mA (range, 10 to 35 mA). Atropine was administered in
13 transesophageal atrial pacing stress echocardiography
studies (mean dose, 0.58 6 0.26 mg; range, 0.50 to
1.50 mg) because of Wenkebach second-degree heart block.
The baseline and peak stress heart rates and blood
pressures are shown in Table 1. Target heart rate was
achieved more often with transesophageal atrial pacing
stress echocardiography (98%) than with dobutamine (89%)
(p 5 0.001). With pacing, there was a mild increase in
systemic blood pressure. Dobutamine stress echocardiogra-
phy was associated with greater variability in systolic blood
pressure response. Development of regional wall motion
abnormalities was the end point for dobutamine stress
echocardiography and transesophageal atrial pacing stress
echocardiography in five patients and one patient, respec-
tively (p 5 0.219). Intolerable symptoms were the end point
for four patients with transesophageal atrial pacing and one
patient with dobutamine stress echocardiography (p 5
0.31). Angina was the end point for one patient for both
tests. Nonsustained ventricular tachycardia (two patients)
and hypotension (one patient) were additional end points
during dobutamine stress echocardiography.
Symptoms during transesophageal atrial pacing stress
echocardiography and dobutamine stress echocardiography
are compared in Table 2. Symptoms were more frequent
Table 1. Comparison of Hemodynamic Variables Between
Dobutamine Stress Echocardiography and Transesophageal
Atrial Pacing Stress Echocardiography
Measurement
Mean 6 SD
p Value*DSE TAP
Heart rate (beats/min)
Baseline 69 6 12 72 6 11 0.003*
Peak 133 6 11 132 6 9 0.559
Change in 63 6 14 57 6 13 0.018
Systolic blood pressure
(mm Hg)
Baseline 143 6 21 144 6 19 0.482
Peak 142 6 29 151 6 20 0.0001
Change in 21 6 25 8 6 15 0.0001
Diastolic blood pressure
(mm Hg)
Baseline 80 6 9 78 6 8 0.451
Peak 74 6 11 83 6 12 0.0001
Change in 26 6 12 5 6 12 0.0001
*From paired t test.
DSE 5 dobutamine stress echocardiography; TAP 5 transesophageal atrial
pacing stress echocardiography.
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during dobutamine stress echocardiography (51 patients)
than during the transesophageal procedure (32 patients)
(p 5 0.008). Common symptoms during transesophageal
atrial pacing stress echocardiography were gagging during
insertion of the catheter and mild retrosternal discomfort,
which resolved with termination of pacing. Retrosternal
discomfort occurred in 20 patients but was an end point in
only four transesophageal atrial pacing stress echocardiog-
raphy studies. Pacing of the diaphragm was not observed.
Small intravenous doses of midazolam were administered in
23 of the transesophageal atrial pacing stress echocardiog-
raphy studies at a mean dose of 2.1 6 1 mg (range, 1 to
4 mg). Dysrhythmias occurred more frequently during
dobutamine stress echocardiography.
The mean patient acceptance scores for dobutamine stress
echocardiography and transesophageal atrial pacing stress
echocardiography were 4.2 6 0.9 and 4.0 6 0.9, respectively
(p 5 0.11). Forty-four patients preferred dobutamine stress
echocardiography, 29 preferred the transesophageal proce-
dure and 27 had no preference.
Duration of tests. The mean duration of transesophageal
stress echocardiography was 8.6 6 3.6 min (5.0 to
21.0 min). This was significantly shorter (p 5 0.0001) than
the dobutamine studies (15.1 6 3.9 min; 7.3 to 25.1 min).
The recovery period after termination of pacing was signif-
icantly shorter with transesophageal stress (1.0 6 2.8 min)
than with dobutamine stress (13.9 6 7.5 min) (p 5 0.0001).
Agreement between dobutamine stress echocardiography
and transesophageal atrial pacing stress echocardiogra-
phy. Among 1,599 segments evaluable by both techniques
at rest, agreement was complete (with 1 to 5 scoring) in
1,478 segments (92%). Among 1,579 segments evaluable
during stress, there was agreement (normal or abnormal) in
1,436 segments (91%). There was exact agreement (with 1
to 5 scoring) in 1,352 segments (86%). The coefficient of
agreement (kappa) for exact interpretation of individual
segments at baseline ranged from 0.57 (for mid inferosep-
tum) to 1.0 (for basal and mid anteroseptum and mid
anterolateral segments). The mean coefficient of agreement
at baseline was 0.79 6 0.04. With stress, the coefficient of
agreement ranged from 0.53 (for mid inferoseptum) to 0.88
(for basal inferior segments). The mean coefficient of
agreement with stress was 0.57 6 0.04.
Interpretations of the two stress echocardiographic meth-
ods are compared in Table 3. For classification of studies as
normal, ischemia, infarction or resting wall motion abnor-
malities with ischemia, there was agreement between do-
butamine stress echocardiography and transesophageal atrial
pacing stress echocardiography in 84 of 100 studies (84%),
kappa 0.77. In six of the 16 discordant studies, transesoph-
ageal atrial pacing identified a single segment in the septum
or the inferobasal segment as abnormal. These segments
were considered normal during dobutamine stress echocar-
diography. In two studies, transesophageal atrial pacing
stress echocardiography caused worsening of wall motion
abnormality in segments with resting wall motion abnor-
mality; this worsening was not seen during dobutamine
stress echocardiography.
When wall motion abnormalities were summarized by
coronary artery territory as normal, ischemia, infarction or
resting wall motion abnormalities with ischemia, the aver-
age agreement for the coronary artery territories was 0.70 6
0.05. Kappa values were 0.72 for left anterior descending
artery territory, 0.74 for right coronary and 0.65 for the left
circumflex artery.
In Table 4, stress electrocardiography and wall motion
score index and ejection fraction at rest and at peak are
compared for the two stress modalities. Ejection fraction at
peak stress was higher with dobutamine (69% 6 11% vs.
61% 6 11%; p 5 0.0001). The ischemic threshold was
lower for dobutamine stress echocardiography (110 6 20
Table 2. Comparison of Symptoms and Dysrhythmias Between
Dobutamine Stress Echocardiography and
Transesophageal Atrial Pacing Stress Echocardiography
No. of
Patients
McNemar’s
p ValueDSE TAP
Chest pain 27 20 0.178
Other symptoms* 25 16 0.117
Complex VE/NSVT 8 1 0.016
Supraventricular tachycardia 5 0 0.063
*Includes 16 patients with gagging during TAP and 12 patients with tremors, 8 with
nausea, 5 with headache and 4 with lightheadedness during DSE.
DSE 5 dobutamine stress echocardiography; NSVT 5 nonsustained ventricular
tachycardia; TAP 5 transesophageal atrial pacing stress echocardiography; VE 5
ventricular ectopy.
Table 3. Comparison of Stress Echocardiography Interpretations Between Dobutamine Stress
Echocardiography and Transesophageal Atrial Pacing Stress Echocardiography
Dobutamine Stress
Echocardiography
Transesophageal Atrial Pacing Stress Echocardiography
Normal Ischemia
Infarction
and Ischemia Infarction
Normal 28 10 0 0
Ischemia 3 21 1 0
Infarction and ischemia 0 0 30 0
Infarction 0 0 2 5
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beats/min) than for transesophageal atrial pacing stress
echocardiography (121 6 13 beats/min) (p 5 0.0001). The
order of testing did not have a significant effect on the
duration, baseline or stress wall motion score index, or
ischemic threshold of either test.
Accuracy of dobutamine stress echocardiography and
transesophageal atrial pacing stress echocardiography.
Fourteen patients with positive results of both dobutamine
stress echocardiography and transesophageal atrial pacing
stress echocardiography underwent coronary angiography.
Thirteen had significant coronary artery disease. The other
patient had previously had an inferior myocardial infarction;
rest inferior and inferoseptal hypokinesis worsened with
both modalities of stress echocardiography. Mild coronary
artery disease (20% to 30% stenoses) was found on angiog-
raphy.
DISCUSSION
The results of this study show that transesophageal atrial
pacing stress echocardiography is a safe, feasible and effi-
cient method for assessment in patients with suspected or
known coronary artery disease. The protocol for transesoph-
ageal atrial pacing stress echocardiography was significantly
shorter than that for dobutamine stress echocardiography.
Recovery times were also shorter, with rapid return to
baseline heart rate and wall motion when pacing was
terminated. Recent improvements in the design of catheters
for transesophageal atrial pacing permit pacing with lower
energy levels, so that this procedure is well tolerated.
Transesophageal atrial pacing stress echocardiography was
satisfactory in patient acceptance, although 23 patients
received midazolam intravenously, and none required this
drug with dobutamine stress echocardiography.
There was good agreement of the two stress echocardio-
graphic methods in assessment of wall motion abnormali-
ties. This was true when the two techniques were compared
for their ability to induce ischemia and when wall motion
scores were compared on a segment-by-segment basis.
Although coronary angiography findings were available in
only a small subset of patients, the good agreement of the
two techniques suggests that transesophageal atrial pacing
stress echocardiography has a diagnostic accuracy similar to
that of dobutamine stress echocardiography, a well-
validated stress testing modality for the detection of coro-
nary artery disease (1–4).
Transesophageal atrial pacing has been used simulta-
neously with transesophageal echocardiography (8,11,12)
and also with transthoracic echocardiography (9,10,13,14)
for the detection of ischemic heart disease. These studies
showed variable feasibility (77% to 100%), sensitivity (83%
to 93%) and specificity (76% to 100%) for the detection of
angiographic coronary artery disease.
The hemodynamic effects of transesophageal atrial pacing
(19–21) and dobutamine stress echocardiography (22) have
been studied but have not previously been compared.
Hemodynamic studies during atrial pacing have demon-
strated that the oxygen demands of the heart are increased
and myocardial lactate production is increased in patients
with angina (23). During atrial pacing, heart rate is in-
creased without an augmentation of cardiac output (20). In
contrast, both heart rate and cardiac output increase during
dobutamine stress testing (22). In the present study, peak
heart rates were similar with both stress modalities, but
systolic and diastolic blood pressures were modestly higher
with transesophageal atrial pacing. The ejection fraction at
peak stress was higher with dobutamine stress. The isch-
emic threshold was approximately 10 beats/min higher with
transesophageal atrial pacing than that observed with do-
butamine stress echocardiography. This was not unex-
pected, because of the inotropic effects of dobutamine.
Limitations. Coronary angiographic data were insufficient
for an estimation of the relative diagnostic accuracy of
transesophageal atrial pacing stress echocardiography and
dobutamine stress echocardiography. However, the agree-
ment of the test results was good. In the transesophageal
atrial pacing stress echocardiography studies preceded by
dobutamine stress echocardiography, the resting heart rate
was higher (by 5 6 11 beats/min). Although a 20-min
period separated the two tests, a residual dobutamine effect
may have potentiated ischemia induced by transesophageal
atrial pacing stress echocardiography. Order of testing did
not affect test agreement, however.
Limitations of transesophageal atrial pacing stress echocar-
diography include the requirement for intact atrioventricular
conduction and absence of significant esophageal disease.
Additionally, some patients required an anxiolytic agent.
Implications. Our findings may have important implica-
tions for the clinical assessment and investigation of coro-
Table 4. Comparison of Stress Echocardiography, Wall Motion
Score Index, and Ejection Fraction Between Dobutamine Stress
Echocardiography and Transesophageal Atrial Pacing Stress
Echocardiography
Variable DSE TAP p Value
Stress electrocardiography
(No. of patients)
Negative 59 57 0.957*
Positive 22 18
Nondiagnostic 19 25
Wall motion score index
(mean 6 SD)
Baseline 1.2 6 0.3 1.2 6 0.3 0.660†
Peak 1.3 6 0.4 1.4 6 0.4 0.383†
Ejection fraction
(% [mean 6 SD])
Baseline 59 6 8 59 6 8 0.658†
Peak 69 6 11 61 6 11 0.0001†
*For testing marginal homogeneity. †From paired t test.
DSE 5 dobutamine stress echocardiography; TAP 5 transesophageal atrial
pacing stress echocardiography.
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nary disease. Dobutamine-atropine stress protocols are
more labor intensive than transesophageal atrial pacing
stress echocardiography or exercise echocardiography. Ad-
verse drug effects and the prolonged recovery period are
limitations of dobutamine stress. Although the use of an
esophageal catheter might be expected to be less appealing
to the patient, because of mild oral analgesia and midazolam
administration in 23%, this was not found to be the case.
Intermediate stages of transesophageal atrial pacing stress
echocardiography were utilized to allow for detection of new
or worsened wall motion abnormalities at heart rates lower
than the target heart rate. However, an even more rapid
protocol would be feasible. Thus, transesophageal atrial
pacing stress echocardiography can find application in a
clinical context in which a rapid test with no adverse drug
effects and a rapid return to baseline are desired. Trans-
esophageal atrial pacing stress echocardiography may also
find a niche in the evaluation of patients who are intolerant
of pharmacologic stress echocardiography, who have chro-
notropic incompetence (including those receiving beta-
blockers) or who require rapid evaluation of chest pain.
Reprint requests and correspondence: Dr. Patricia A. Pellikka,
Division of Cardiovascular Diseases and Internal Medicine, Mayo
Clinic, 200 First Street SW, Rochester, Minnesota 55905. E-mail:
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